focus -WSS

focus

author：hotspot 2025-08-25 07:28:16 - browse：54

Most everything is looking up for Orexo, the company reported on its second quarter earnings call on Tuesday. That is, everything but its digital therapies pipeline.

The Swedish pharmaceutical company, which makes almost all of its money from U.S. sales of its drug for opioid dependence, notched a number of important victories in the quarter: It successfully defended its patents in a case against Sun Pharmaceuticals, it resolved a packaging issue that was holding up the approval of its long-acting rescue medication, and it grew revenues for Zubsolv, its most important product. The company trimmed its losses to 12.6 million SEK, or $1.2 million, and executives reported that with fewer one-time expenses on the horizon, profitability was “in sight.”

“We are at an exciting turning point for the company and I hope our self confidence and optimism is something that you can share,” CEO Nikolaj Sørensen said on the company’s earnings call while cautioning that “there’s a lot more work to be done.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

WSS

N.Y. state detects polio case, first in the U.S. since 2013

A new study sees potential in DNA sequencing of infants

Why 40% Americans with Parkinson’s don’t see a neurologist

New research casts further doubt on a common procedure used with IVF

N.Y. state detects polio case, first in the U.S. since 2013

Beach reads and more: STAT's 2023 summer book list

explore

focus

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Living with Fabry disease, a condition that causes chronic pain

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Oak trusses raised to roof of fire

Apple is now the first public company to be valued at $3 trillion

Study: Pain burden is higher in Black NFL players than white ones

As demand for Covid shots wanes, Moderna seeks its next success

Lecanemab for Alzheimer's is coming. Is the health system ready?

Dobbs anniversary: the lost opportunity of abortion as health care

Lecanemab for Alzheimer's is coming. Is the health system ready?

knowledge

California’s proposed $25 per hour health care minimum wage

California’s proposed $25 per hour health care minimum wage

Petition to FDA: Get the lead out of consumer hair dyes

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Petition to FDA: Get the lead out of consumer hair dyes

Study: Pain burden is higher in Black NFL players than white ones

entertainment

focus

Wikipedia

hotspot